Melatonin to prevent heart and cancer risks in older adults
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether taking a melatonin supplement every night for two years reduces the risk of heart problems and cancer in older adults. If you are generally healthy and between 60 and 74, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 60 and 74 years old and of Han Chinese background.
- Women must have gone through menopause.
- You must not have had cancer (except non-melanoma skin cancer), a heart attack, stroke, or heart-related procedures.
- You must not have mental illness, serious infections, or conditions like kidney stones, liver disease, or sleep apnea.
- You must be willing to take a supplement daily and attend follow-up visits for about 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how sleep patterns affect the risk of heart disease and stroke in older adults. It aims to help improve heart health through better sleep.
This study tests whether melatonin can help improve heart health in midlife women with high blood pressure. It involves taking a melatonin pill or placebo for several weeks and checking blood pressure and other health markers.
This trial tests if adding melatonin to standard heart medication helps protect the heart muscle in people with cardiomyopathy. If you are stable on your current heart meds, you may be able to join.
This study tests whether taking 5 mg of melatonin can improve thinking and brain health over time in older adults with early, mild symptoms. You may help researchers learn which brain changes and measures improve with melatonin.
This trial tests whether adding melatonin, a natural sleep hormone, to standard chemotherapy before surgery can help treat breast cancer. It aims to see if melatonin makes the chemotherapy work better or reduces side effects.
This study tests whether adding a melatonin supplement to a type of talk therapy for insomnia (called CBT-I) helps older adults sleep better. It aims to improve sleep quality and reduce insomnia symptoms.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.